VYNE Therapeutics Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Bridgewater, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
VYNE Therapeutics Inc. has filed 659 SEC EDGAR filings since 07 Jan 2013

SEC filing history

Showing 576-600 of 659 matching filings.

Per page
25
Current page
24
4

PRIMARY DOCUMENT

Filing date
12 Dec 2018
Reporting date
10 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38356

8-K

Filing date
10 Dec 2018
Reporting date
10 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38356

8-K

Filing date
13 Nov 2018
Reporting date
08 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38356

8-K

Filing date
07 Nov 2018
Reporting date
07 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38356

8-K

Filing date
09 Oct 2018
Reporting date
08 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90268

SC 13G filing

Filing date
13 Aug 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

PRIMARY DOCUMENT

Filing date
10 Aug 2018
Reporting date
29 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38356

8-K

Filing date
01 Aug 2018
Reporting date
01 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
26 Jul 2018
Reporting date
24 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
26 Jul 2018
Reporting date
02 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38356

8-K

Filing date
28 Jun 2018
Reporting date
28 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90268

JANUS HENDERSON GROUP PLC OWNS 10.1% OF MENLO

Filing date
10 May 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
09 May 2018
Reporting date
03 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38356

8-K

Filing date
09 May 2018
Reporting date
09 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38356

8-K

Filing date
07 May 2018
Reporting date
03 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 May 2018
Reporting date
03 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 May 2018
Reporting date
03 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 May 2018
Reporting date
03 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38356

8-K

Filing date
24 Apr 2018
Reporting date
24 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38356

8-K

Filing date
09 Apr 2018
Reporting date
08 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38356

8-K

Filing date
28 Mar 2018
Reporting date
28 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .